Skip to main navigation
menu

Aclaris - Corp Menu

  • About Us »
    « Back
    • Overview
    • Leadership
    • Board of directors
    • Partnerships
    • Corporate compliance
    • Contact
  • Research »
    « Back
    • Diseases and conditions
    • Pipeline
    • Drug discovery
    • Clinical trials
    • Publications
    • Investigator initiated studies
  • Products
  • Citizenship »
    « Back
    • Social responsibility
    • Scientist development program
    • Aclaris support
  • Careers
  • Insights
  • Investors »
    « Back
    • Investor overview
    • Stock information
    • Press releases
    • Events
    • Investor presentations
    • SEC filings
    • Corporate governance
    • Investor FAQs
    • Email alerts

Aclaris - Extras Menu

  • Media resources
  • Contact us

Aclaris - Corp Menu

  • About Us »
    « Back
    • Overview
    • Leadership
    • Board of directors
    • Partnerships
    • Corporate compliance
    • Contact
  • Research »
    « Back
    • Diseases and conditions
    • Pipeline
    • Drug discovery
    • Clinical trials
    • Publications
    • Investigator initiated studies
  • Products
  • Citizenship »
    « Back
    • Social responsibility
    • Scientist development program
    • Aclaris support
  • Careers
  • Insights
  • Investors »
    « Back
    • Investor overview
    • Stock information
    • Press releases
    • Events
    • Investor presentations
    • SEC filings
    • Corporate governance
    • Investor FAQs
    • Email alerts

Aclaris - Investor Relations

  • Investor overview
  • Stock information
  • Press releases
  • Events
  • SEC filings
  • Corporate governance
  • Investor presentations
  • Investor FAQs
  • Email alerts
Investor contact
For investor related questions, please email
investors@aclaristx.com
Media contact
& resources »

Investor Overview

Stock quote
  
 
VOLUME:
View stock performance »

Copyright West LLC. Minimum 15 minutes delayed.

Investor Overview

Press Releases
November 12, 2019
Aclaris Therapeutics to Present at Upcoming Investor Conferences
November 7, 2019
Aclaris Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Highlights and an Update on R&D Programs
October 31, 2019
Aclaris Therapeutics to Announce Third Quarter 2019 Financial Results on November 7, 2019
View all »
Events
Dec 4, 2019
3:05 PM EST
Aclaris Therapeutics, Inc. at Evercore ISI 2nd Annual HealthCONx Conference
Nov 7, 2019
5:00 PM EST
Q3 2019 Aclaris Therapeutics Inc. Earnings Conference Call
Oct 24, 2019
4:30 PM EDT
Aclaris Therapeutics Pivotal Phase 3 Trial for the Treatment of Common Warts (THWART-1)
View all »
Feature presentation
More presentations coming soon.

Aclaris - Footer Menu

  • Terms of use
  • Privacy policy
  • Media resources
  • Contact us
© 2019 Aclaris Therapeutics, Inc. All rights reserved. Unless otherwise noted, all trademarks referenced on this page are owned by Aclaris Therapeutics.